Villasan, Isidro B.

HRN: 24-35-32  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2024
CEFTRIAXONE 1G (VIAL)
02/27/2024
03/05/2024
IV
1g
Q12h
Metabolic Encephalopathy Probably 2° To Hyponatremia; T/C Sepsis
Waiting Final Action 
02/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/27/2024
03/05/2024
IV
500mg
Q8H
Metabolic Encephalopathy Probably 2° To Hyponatremia; T/C Sepsis
Waiting Final Action 
02/28/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/28/2024
03/06/2024
IV
4.5gms
Q8
CAP HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: